Evermide 25 mg (Lenalidomide)
| Active Ingredient | Lenalidomide |
|---|---|
| Indication: | Multiple myeloma, Lepra reaction |
| Manufacturer: | Neova Biogene Private Limited |
| Packaging | 30 Capsules in bottle |
| Strength | 25mg |
| Delivery Time | 6 To 15 days |
Evermide 25mg contains Lenalidomide, a potent immunomodulatory drug used primarily in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL). It works by enhancing the immune system, inhibiting the growth of cancer cells, and blocking the formation of blood vessels that supply tumors.
Lenalidomide is especially effective when used in combination with dexamethasone or other cancer therapies. Evermide 25 mg tablets are taken orally once daily, usually in cycles (e.g., 21 days on, 7 days off) depending on the treatment protocol. The dosage and duration are carefully adjusted based on blood counts and patient response.








There are no reviews yet.